
Medical Stocks in the News: Celldex Therapeutics (NASDAQ:CLDX), NeuroMetrix (NASDAQ:NURO)
Celldex Therapeutics (NASDAQ:CLDX) is lower Monday afternoon after its net loss widened and revenue declined compared to the year-ago period. Results were better than Wall Street’s expectations but could not fend off sellers. In early afternoon action, shares of the biopharmaceutical company are down 11% at $26.15 and traded earlier as low as $25.76. The stock moves within a 52-week range of $9.13 – $38.84. Celldex … Continue reading Medical Stocks in the News: Celldex Therapeutics (NASDAQ:CLDX), NeuroMetrix (NASDAQ:NURO)